46 results
8-K
EX-1.1
TPST
Tempest Therapeutics, Inc.
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
Change. No material labor dispute with the employees of the Company or any of its subsidiaries, or with the employees of any principal supplier
8-K
EX-10.1
5q1wycsy 5r
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
8-K
EX-1.1
r1y 6asmte4c
23 Jul 21
Other Events
5:20pm
8-K
EX-99.2
5a6i83ui5azyjlfxlkq6
16 Jul 21
Other Events
4:31pm
8-K
EX-99.1
0th7h
16 Jul 21
Other Events
4:31pm
424B3
18neogyobl e24t
11 May 21
Prospectus supplement
5:19pm